IgGenix is a biotechnology company located in South San Francisco that aims to develop groundbreaking therapies for individuals with allergies. Their mission is to improve the lives of millions by offering innovative solutions for allergic diseases. At the core of their work is their SEQ SIFTER™ antibody discovery platform, which provides a deep understanding of molecular immunology.

By leveraging this knowledge, IgGenix develops products that offer faster and more sustained clinical responses. Their first lead development candidate focuses on food allergies and uses a revolutionary approach to block the allergic cascade. Continuously making advancements, IgGenix recently demonstrated the potential of an IgG4 monoclonal antibody-based treatment for peanut allergy.

They have also obtained a patent covering the generation of allergen-specific antibodies. With a robust pipeline, IgGenix is actively engaged in research across a range of allergic diseases, targeting both food and environmental allergies. Their team of experts, including distinguished scientific co-founders and a dedicated advisory board, ensures the development of cutting-edge therapies.

If you share their passion for innovation and want to contribute to their mission, IgGenix offers career opportunities in a fast-paced, collaborative environment. Join their talented team and make a difference in the lives of millions